SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 28 filers reported holding SCPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -36.2% | 5,122 | -11.0% | 0.00% | – |
| Q2 2023 | $58 | -91.3% | 5,756 | -92.2% | 0.00% | – |
| Q1 2023 | $666 | -86.7% | 73,448 | +8923.1% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 814 | +5.7% | 0.00% | – |
| Q2 2021 | $5,000 | -87.2% | 770 | -86.8% | 0.00% | – |
| Q1 2021 | $39,000 | +225.0% | 5,849 | +159.0% | 0.00% | – |
| Q4 2020 | $12,000 | -50.0% | 2,258 | -27.7% | 0.00% | – |
| Q3 2020 | $24,000 | +9.1% | 3,123 | +4.6% | 0.00% | – |
| Q2 2020 | $22,000 | +2100.0% | 2,985 | +2002.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 142 | +14100.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 2,087 | +959.4% | 0.00% | – |
| Q4 2018 | $1,000 | -93.8% | 197 | -92.8% | 0.00% | – |
| Q3 2018 | $16,000 | +433.3% | 2,718 | +278.6% | 0.00% | – |
| Q2 2018 | $3,000 | -84.2% | 718 | -52.9% | 0.00% | – |
| Q1 2018 | $19,000 | – | 1,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,857,143 | $35,429,000 | 2.71% |
| Orbimed Advisors | 3,409,865 | $42,282,000 | 0.52% |
| AWM Investment Company, Inc. | 213,317 | $2,645,000 | 0.51% |
| DAFNA Capital Management LLC | 55,844 | $692,000 | 0.34% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 40,373 | $501,000 | 0.07% |
| Alyeska Investment Group, L.P. | 223,438 | $2,771,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,330 | $302,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 69,500 | $862,000 | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 36,206 | $449,000 | 0.00% |
| PEDDOCK CAPITAL ADVISORS, LLC | 100 | $1,000 | 0.00% |